-
Nutrition and Dietary Supplements
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Folic acid supplementation for the prevention of neural tube defects: promotion and use
Review
(1606) Views (805) Full article downloads
Authors: Haydi Al-Wassia, Prakesh S Shah
Published Date September 2010
Volume 2010:2 Pages 105 - 116
DOI: http://dx.doi.org/10.2147/NDS.S8554
Haydi Al-Wassia1, Prakesh S Shah1,2,3,41Department of Pediatrics, Mount Sinai Hospital, Toronto, Canada; 2Department of Pediatrics, Division of Neonatology, University of Toronto, Canada; 3Mother-Infant Care Research Center, Mount Sinai Hospital, Toronto, Canada; 4Department of Health Policy, Management and Evaluations, University of Toronto, Canada
Abstract: Observational and randomized controlled studies have shown that periconceptional folic acid (FA) supplementation can significantly reduce the risk of neural tube defects (NTDs). Countries across the world have adopted various strategies to increase awareness and to promote the use of FA. Nevertheless, health promotion and educational campaigns have proven to be ineffective in achieving the goal of increasing FA intake by the at-risk group. Mandatory FA fortification was a further step taken by some countries on the course toward improving folate status in the general population. Although some researchers advocate for extra folate to be added to the food supply, a number of governments have refrained from adopting the policy of mandatory fortification because of concerns raised over the potential side effects, such as cancer risk; however, epidemiological confirmation is inconsistent. After several years of the proven association between prenatal supplementation of FA and prevention of NTD, uncertainty, controversy, and indecision still hinder FA promotion and use. In this review, we summarize approaches taken by various countries and provide a framework for further steps in this area.
Keywords: folic acid, fortification, neural tube defect
Readers of this article also read:
Nutritional supplementation to prevent and slow the progression of chronic kidney disease: focus on bicarbonate
Homocysteine and folate levels as indicators of cerebrovascular accident
Cholesterol-lowering phytosterols: factors affecting their use and efficacy
Role of green tea in reduction of cardiovascular risk factors
The effect of β-carotene on common cold incidence is modified by age and smoking: evidence against a uniform effect in a nutrient–disease relationship
Prenatal nutritional influences on obesity risk in offspring
Use of dietary supplements among US adults with asthma
Efficacy of a novel, biologically active food supplement in type 2 diabetes mellitus: a patient-blinded, prospective, clinical trial
Vitamin D deficiency in HIV-infected patients: a systematic review
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Clinical evidence supporting the use of an activated clinoptilolite suspension as an agent to increase urinary excretion of toxic heavy metals
- Polyphenols as dietary supplements: A double-edged sword
- Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
- Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee




